
For this episode, we sit down with Banishree Saha, Global Biomarkers Lead at Takeda, who has worked in fields such as academic liver biology to translational biomarker work, over the course of her 20-year career. She walks us through what biomarkers really are, how flow cytometry went from single-color panels to capturing 40 proteins simultaneously, and why that explosion in data has made systems thinking the only way forward.Banishree talks about AI's strengths and weaknesses, and makes the case that the scientists most at risk from AI aren't the ones who know too much biology. But are the ones who don't know enough to catch when the model is wrong.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.

Episode 24: Beyond Correlation - Teaching AI the Rules of Biology

Episode 23: When Biologists Start Thinking Like Engineers

Episode 22: The Model Was Never Built for Her

Episode 21: Glass Box Wins - What Pharma Actually Trusts in AI
Free AI-powered recaps of From Models to Medicine and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.